{"filing":{"accession_number":"0001104659-26-107729","cik":"0002072188","ticker":"BIOT","company_name":"INSTINCT BIO TECHNICAL CO HOLDINGS INC.","form":"6-K","filing_date":"2026-09-15","report_date":"2026-09-15","primary_document":"tm2625442d1_6k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/2072188/000110465926107729/tm2625442d1_6k.htm"},"events":[{"id":33508,"run_id":30810,"accession_number":"0001104659-26-107729","anchor_item_number":"EX-99.1","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.98,"summary":"Nasdaq notified Instinct Bio on September 9–10, 2026 that the Company failed three continued listing requirements: minimum market value of listed securities (MVLS) below $50M, minimum market value of publicly held shares (MVPHS) below $15M, and minimum bid price below $1.00 per share. The Company has 180 calendar days to regain compliance or face delisting, with the option to appeal or transfer to Nasdaq Capital Market. This is a classic delisting-risk disclosure under Item 3.01 equivalent, materially threatening the Company's continued listing status.","company_name":"INSTINCT BIO TECHNICAL CO HOLDINGS INC.","ticker":"BIOT","filing_date":"2026-09-15","form":"6-K","submitted_at":null,"items":[{"id":36969,"accession_number":"0001104659-26-107729","item_number":"EX-99.1","item_title":"tm2625442d1_ex99-1.htm","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.98,"reasoning":"Nasdaq notified Instinct Bio on September 9–10, 2026 that the Company failed three continued listing requirements: minimum market value of listed securities (MVLS) below $50M, minimum market value of publicly held shares (MVPHS) below $15M, and minimum bid price below $1.00 per share. The Company has 180 calendar days to regain compliance or face delisting, with the option to appeal or transfer to Nasdaq Capital Market. This is a classic delisting-risk disclosure under Item 3.01 equivalent, materially threatening the Company's continued listing status.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-09-15T12:45:45.827751+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":36969,"accession_number":"0001104659-26-107729","item_number":"EX-99.1","item_title":"tm2625442d1_ex99-1.htm","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.98,"reasoning":"Nasdaq notified Instinct Bio on September 9–10, 2026 that the Company failed three continued listing requirements: minimum market value of listed securities (MVLS) below $50M, minimum market value of publicly held shares (MVPHS) below $15M, and minimum bid price below $1.00 per share. The Company has 180 calendar days to regain compliance or face delisting, with the option to appeal or transfer to Nasdaq Capital Market. This is a classic delisting-risk disclosure under Item 3.01 equivalent, materially threatening the Company's continued listing status.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-09-15T12:45:45.827751+00:00","company_name":"INSTINCT BIO TECHNICAL CO HOLDINGS INC.","ticker":"BIOT","filing_date":"2026-09-15"}]}